Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...

CVS (operating in Hawaii as Longs Drugs) is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment ...

Maniar says because of these concerns, many people with allergies don't carry an EpiPen or generic injectable. According to ARS Pharma, the manufacturer of the nasal spray, only 3.2 million of the ...

several companies created EpiPen substitutions and the Food and Drug Administration approved the first generic alternative, but EpiPen had name-brand recognition. Speaking with PEOPLE at the time ...

A backlash against the hugely increased price of its EpiPen product has led Mylan to announce the launch of a generic version. The company has become engulfed in controversy around its US EpiPen ...

People or entities who purchased EpiPen® or generic EpiPen directly from Mylan or Teva, for resale, at any time during the period from March 13, 2014, until the date on which the Court entered ...

Epinephrine has been used since 1901 and is ... As a result of the outcry, Mylan began selling an “authorized generic” for ...

The complaint centers on generic, rather than brand-name ... competitive coordination between companies, as opposed to the EpiPen outrage which involved only Mylan. In that case, the company ...

Epinephrine 0.15mg (1:2000); prefilled auto-injector; contains sulfites. Epinephrine acts on both alpha- and beta-adrenergic receptors. Through its action on alpha-adrenergic receptors ...

There's a very good reason why the EpiPen's 500% price increase drew so much attention, even though there are other emergency auto-injecting devices available that can be used to treat severe ...

The company has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) — a critical regulatory step. This product is now ready to be converted into a finished drug product.